𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Carcinogenic evaluation of 2,3-dimethyl-2,3-dinitrobutane via the mouse skin bioassay

✍ Scribed by Tirumuru V. Reddy; F. Bernard Daniel; Merrel Robinson; Greg R. Olson


Publisher
John Wiley and Sons
Year
1994
Tongue
English
Weight
149 KB
Volume
14
Category
Article
ISSN
0260-437X

No coin nor oath required. For personal study only.

✦ Synopsis


Female SENCAR mice initiated with 2,3-dimethyl-2,3-dinitrobutane (DMDNB) and promoted with 12-0tetradecanoylphorol-13-acetate (TPA) via the SENCAR mouse skin bioassay did not exhibit a significant increase in skin tumors. The mice received 20 mg kg-' DMDNB divided into six intragastric doses over 2 weeks and were promoted three times per week for 20 weeks.


πŸ“œ SIMILAR VOLUMES


The prostaglandin E2 receptor, EP2, regu
✍ Kyung-Soo Chun; Robert Langenbach πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 790 KB

We previously reported that cycloogenase (COX)-2-generated prostaglandin E2 (PGE2) had anti-apoptotic effects in UVB-exposed mouse skin that involved EP2-mediated signaling (Chun et al., Cancer Res. 2007; 67: 2015). Because survivin is a regulator of cell survival, the possible involvement of COX-2

The effects of the carcinogen, 1,2-dimet
✍ Richards, Thomas C. πŸ“‚ Article πŸ“… 1981 πŸ› John Wiley and Sons 🌐 English βš– 763 KB

## Abstract 1,2‐dimethylhydrazine (DMH), administered weekly to mice for 20 weeks, induces tumors in the distal segment of colon. Tumors are preceded by enlargement of the mucosal glands resulting from increases in the number of total cells and ^3^H‐thymidine labeled cells/crypt. Cells located in t